Easywell Biomedicals, Inc. (TPEX:1799)
Taiwan
· Delayed Price · Currency is TWD 38.05
0.00 (0.00%)
Apr 29, 2026, 1:30 PM CST
Easywell Biomedicals Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -73.14 | -97.47 | -144.82 | -161 | -150.39 | Upgrade
|
| Depreciation & Amortization | 91.02 | 79.78 | 65.13 | 66.55 | 70.78 | Upgrade
|
| Other Amortization | 0.11 | 0.1 | 0.02 | - | 0.1 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.18 | -0.03 | - | - | -0.24 | Upgrade
|
| Stock-Based Compensation | 3.66 | 12.44 | 16.96 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | -2.65 | 4.98 | - | - | - | Upgrade
|
| Other Operating Activities | -11.61 | 9.24 | -25.14 | -7.46 | -37.23 | Upgrade
|
| Change in Accounts Receivable | 4.43 | 23.38 | -47.17 | 13.08 | -5.66 | Upgrade
|
| Change in Inventory | 96.16 | -213.19 | -15.59 | -3.92 | 9.95 | Upgrade
|
| Change in Accounts Payable | -36.01 | 35.53 | 7.17 | 1.78 | 0.08 | Upgrade
|
| Change in Unearned Revenue | 34.94 | -8.54 | 5.7 | 20.56 | -4.08 | Upgrade
|
| Change in Other Net Operating Assets | 38.31 | 14.9 | -13.72 | 1.9 | 3.39 | Upgrade
|
| Operating Cash Flow | 124.78 | -159.04 | -151.45 | -53.5 | -128.31 | Upgrade
|
| Capital Expenditures | -15.41 | -12.49 | -17.73 | -7.49 | -7.71 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.18 | 0.08 | - | - | 0.24 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -0.26 | -0.82 | - | - | Upgrade
|
| Investment in Securities | -9.84 | -35.15 | 106.38 | 80.14 | -175.07 | Upgrade
|
| Other Investing Activities | 0.03 | 0.17 | -0.37 | 0.01 | - | Upgrade
|
| Investing Cash Flow | -25.04 | -47.66 | 87.46 | 72.66 | -182.54 | Upgrade
|
| Short-Term Debt Issued | 86.58 | 200.1 | 43.93 | - | - | Upgrade
|
| Total Debt Issued | 86.58 | 200.1 | 43.93 | - | - | Upgrade
|
| Short-Term Debt Repaid | -194.4 | -44.56 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -17.16 | -14.19 | -15.47 | -10.55 | -9.45 | Upgrade
|
| Total Debt Repaid | -211.56 | -58.75 | -15.47 | -10.55 | -9.45 | Upgrade
|
| Net Debt Issued (Repaid) | -124.98 | 141.34 | 28.46 | -10.55 | -9.45 | Upgrade
|
| Issuance of Common Stock | 169.17 | 171.84 | 15 | - | 329.76 | Upgrade
|
| Repurchase of Common Stock | - | -0.75 | - | - | - | Upgrade
|
| Other Financing Activities | -186.89 | -49.37 | 134.39 | - | - | Upgrade
|
| Financing Cash Flow | -142.7 | 263.06 | 177.84 | -10.55 | 320.31 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.64 | 6.41 | -9.98 | -2.61 | -1.33 | Upgrade
|
| Net Cash Flow | -44.6 | 62.76 | 103.88 | 6 | 8.14 | Upgrade
|
| Free Cash Flow | 109.37 | -171.53 | -169.17 | -60.99 | -136.02 | Upgrade
|
| Free Cash Flow Margin | 18.31% | -31.74% | -62.28% | -34.09% | -68.95% | Upgrade
|
| Free Cash Flow Per Share | 0.88 | -1.43 | -1.48 | -0.53 | -1.28 | Upgrade
|
| Cash Interest Paid | 22.45 | 21.34 | 19.03 | 17.25 | 16.08 | Upgrade
|
| Cash Income Tax Paid | 0.25 | 0.42 | 0.42 | 0.19 | 0.84 | Upgrade
|
| Levered Free Cash Flow | 89.05 | -42.68 | -117.85 | -28.28 | -79.6 | Upgrade
|
| Unlevered Free Cash Flow | 103.1 | -29.46 | -105.81 | -17.5 | -69.55 | Upgrade
|
| Change in Working Capital | 117.56 | -168.08 | -63.6 | 48.41 | -11.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.